Comparison of time to negative conversion of SARS-CoV-2 between young and elderly among asymptomatic and mild COVID-19 patients: a cohort study from a national containment center
ObjectiveWe aimed to study the relationship between age and time to negative conversion of SARS-CoV-2 in patients with asymptomatic and mild forms of COVID-19.MethodsWe conducted a cohort study including all patients diagnosed with COVID-19 from the national COVID-19 containment center of Tunisia. Patients were subdivided into two cohorts: (under 60 years) and (over 60 years) and were followed up until PCR negativization. Log rank test and Cox regression were applied to compare time to negative conversion between the old group and the young group.ResultsThe study included 289 patients with non-severe forms of COVID-19. Age over 60 was significantly associated with delayed negative conversion in male sex (Hazard ratio (HR): 1.9; 95% CI: 1.2–3.07) and among patients with morbid conditions (HR:1.68; 95% CI: 1.02–2.75) especially diabetics (HR: 2.06; 95% CI: 1.01–4.21). This association increased to (HR:2.3; 95% CI: 1.13–4.66) when male sex and comorbidities were concomitantly present and rose to (HR: 2.63; 95% CI: 1.02–6.80) for men with diabetes. Cox regression analysis revealed a significantly delayed negative conversion in symptomatic patients. Significant interaction was observed between gender and age and between age and chronic conditions.ConclusionAge is associated with delayed negative conversion of viral RNA in certain subgroups. Identifying these subgroups is crucial to know how prioritize preventive strategies in elderly..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Frontiers in Medicine - 11(2024) |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Imen Zemni [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
COVID-19 |
|---|
| doi: |
10.3389/fmed.2024.1217849 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ091371570 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ091371570 | ||
| 003 | DE-627 | ||
| 005 | 20240412091501.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240412s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fmed.2024.1217849 |2 doi | |
| 035 | |a (DE-627)DOAJ091371570 | ||
| 035 | |a (DE-599)DOAJfac3b404aaf8464993794b1434b67463 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a R5-920 | |
| 100 | 0 | |a Imen Zemni |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Comparison of time to negative conversion of SARS-CoV-2 between young and elderly among asymptomatic and mild COVID-19 patients: a cohort study from a national containment center |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a ObjectiveWe aimed to study the relationship between age and time to negative conversion of SARS-CoV-2 in patients with asymptomatic and mild forms of COVID-19.MethodsWe conducted a cohort study including all patients diagnosed with COVID-19 from the national COVID-19 containment center of Tunisia. Patients were subdivided into two cohorts: (under 60 years) and (over 60 years) and were followed up until PCR negativization. Log rank test and Cox regression were applied to compare time to negative conversion between the old group and the young group.ResultsThe study included 289 patients with non-severe forms of COVID-19. Age over 60 was significantly associated with delayed negative conversion in male sex (Hazard ratio (HR): 1.9; 95% CI: 1.2–3.07) and among patients with morbid conditions (HR:1.68; 95% CI: 1.02–2.75) especially diabetics (HR: 2.06; 95% CI: 1.01–4.21). This association increased to (HR:2.3; 95% CI: 1.13–4.66) when male sex and comorbidities were concomitantly present and rose to (HR: 2.63; 95% CI: 1.02–6.80) for men with diabetes. Cox regression analysis revealed a significantly delayed negative conversion in symptomatic patients. Significant interaction was observed between gender and age and between age and chronic conditions.ConclusionAge is associated with delayed negative conversion of viral RNA in certain subgroups. Identifying these subgroups is crucial to know how prioritize preventive strategies in elderly. | ||
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a elderly | |
| 650 | 4 | |a pandemic | |
| 650 | 4 | |a viral clearance | |
| 650 | 4 | |a mild COVID-19 infection | |
| 653 | 0 | |a Medicine (General) | |
| 700 | 0 | |a Imen Zemni |e verfasserin |4 aut | |
| 700 | 0 | |a Imen Zemni |e verfasserin |4 aut | |
| 700 | 0 | |a Cyrine Bennasrallah |e verfasserin |4 aut | |
| 700 | 0 | |a Cyrine Bennasrallah |e verfasserin |4 aut | |
| 700 | 0 | |a Cyrine Bennasrallah |e verfasserin |4 aut | |
| 700 | 0 | |a Ines Charrada |e verfasserin |4 aut | |
| 700 | 0 | |a Wafa Dhouib |e verfasserin |4 aut | |
| 700 | 0 | |a Wafa Dhouib |e verfasserin |4 aut | |
| 700 | 0 | |a Wafa Dhouib |e verfasserin |4 aut | |
| 700 | 0 | |a Amani Maatouk |e verfasserin |4 aut | |
| 700 | 0 | |a Donia Ben Hassine |e verfasserin |4 aut | |
| 700 | 0 | |a Donia Ben Hassine |e verfasserin |4 aut | |
| 700 | 0 | |a Rim Klii |e verfasserin |4 aut | |
| 700 | 0 | |a Meriem Kacem |e verfasserin |4 aut | |
| 700 | 0 | |a Meriem Kacem |e verfasserin |4 aut | |
| 700 | 0 | |a Meriem Kacem |e verfasserin |4 aut | |
| 700 | 0 | |a Manel Ben Fredj |e verfasserin |4 aut | |
| 700 | 0 | |a Manel Ben Fredj |e verfasserin |4 aut | |
| 700 | 0 | |a Manel Ben Fredj |e verfasserin |4 aut | |
| 700 | 0 | |a Hela Abroug |e verfasserin |4 aut | |
| 700 | 0 | |a Hela Abroug |e verfasserin |4 aut | |
| 700 | 0 | |a Hela Abroug |e verfasserin |4 aut | |
| 700 | 0 | |a Salma Mhalla |e verfasserin |4 aut | |
| 700 | 0 | |a Maha Mastouri |e verfasserin |4 aut | |
| 700 | 0 | |a Chawki Loussaief |e verfasserin |4 aut | |
| 700 | 0 | |a Ines Jlassi |e verfasserin |4 aut | |
| 700 | 0 | |a Ines Bouanène |e verfasserin |4 aut | |
| 700 | 0 | |a Ines Bouanène |e verfasserin |4 aut | |
| 700 | 0 | |a Asma Sriha Belguith |e verfasserin |4 aut | |
| 700 | 0 | |a Asma Sriha Belguith |e verfasserin |4 aut | |
| 700 | 0 | |a Asma Sriha Belguith |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Frontiers in Medicine |d Frontiers Media S.A., 2014 |g 11(2024) |w (DE-627)DOAJ000022292 |x 2296858X |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2024 |
| 856 | 4 | 0 | |u https://doi.org/10.3389/fmed.2024.1217849 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/fac3b404aaf8464993794b1434b67463 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.frontiersin.org/articles/10.3389/fmed.2024.1217849/full |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2296-858X |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2024 | ||